Mark B. Faries, MD, is a surgical oncologist specializing in cutaneous oncology. He conducts research relating to melanoma surgery, lymphatic biology and tumor immunology. He is the principal investigator of the Multicenter Selective Lymphadenectomy Trial and has completed trials in minimally invasive lymph node dissection and several immune therapies. He serves as an investigator on several therapeutic clinical trials.